Inhibrx, Inc. - 29 May 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Reporting relationship: 10%+ Owner
Issuer ticker: INBX
Reported as of: 29 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 May 2024, 16:30:04 UTC
Prior SEC filing: 24 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Martin Travers, Authorized Signatory on behalf of Inhibrx, Inc.

Key filing fact

Inhibrx, Inc. filed Form 4 for Inhibrx Biosciences, Inc. (INBX) on 31 May 2024.

Key facts

This page summarizes Inhibrx, Inc.'s Form 4 filing for Inhibrx Biosciences, Inc. (INBX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 May 2024, 16:30.

Change

Previous filing in this sequence was filed on 24 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBX transaction

Common Stock, par value $0.0001 per share

Other

Transaction value
Shares: -13,316,140
Change %: -92%
Price
Shares after: 1,157,926
Date: 29 May 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Inhibrx, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

On January 8, 2024, Inhibrx, Inc. ("RemainCo"), acquired 100 shares, par value $0.0001 per share (the "Common Stock"), of Inhibrx Biosciences, Inc. (the "Issuer"), which at the time constituted all of the issued and outstanding Common Stock of the Issuer. On May 29, 2024, the Common Stock was split, resulting in RemainCo's ownership of an aggregate 14,474,066 shares of Common Stock of the Issuer.

Footnote F2

On May 29, 2024 at 11:59 p.m., New York City time, RemainCo distributed approximately 92% of the Common Stock of the Issuer to the holders of record of RemainCo as of May 17, 2024.